Health ❯ Healthcare ❯ Clinical Trials

Drug Trials

Eli Lilly Trials Lecanemab Bile Duct Cancer Trials Efficacy Studies Phase 3 Trials Weight Loss Drugs Pembrolizumab Targeted Therapy Cancer Research Phase Two Trials Ambroxol PATHFNDR Trials Niraparib Study Double-Blind Trials Phase 1b Trials BHF Funded Trials Fenebrutinib Epcoritamab Mounjaro Trials GLP-1 Drugs

KOMET-007 Shows 600 mg Ziftomenib Plus Venetoclax/Azacitidine Achieves Deep Remissions in NPM1‑Mutated AML

Investigators reported early MRD clearance without added toxicity in an elderly cohort.

FDA Approves Palsonify, First Once-Daily Oral Treatment for Acromegaly

Ambroxol Trial Confirms Safety, Brain Delivery and Early Cognitive Benefits in Parkinson’s Dementia

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug